Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer-Reference-Cited by-同舟云学术

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer

Published:2019-09 Issue:1 Volume:1 Page:68-79
ISSN:2666-0873
Container-title:JACC: CardioOncology
language:en
Short-container-title:JACC: CardioOncology

Author:

Macedo Ariane V.S.,Hajjar Ludhmila A.,Lyon Alexander R.,Nascimento Bruno R.,Putzu Alessandro,Rossi Lorenzo,Costa Rafael B.,Landoni Giovanni,Nogueira-Rodrigues Angélica,Ribeiro Antonio L.P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Oncology

Reference68 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer;Evans;Int J Radiat Oncol Biol Phys,2006

3. Long-term cardiac mortality after radiotherapy of breast cancer--application of the relative seriality model;Gagliardi;Br J Radiol,1996

4. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis;Amir;J Natl Cancer Inst,2011

5. Anticancer agents and cardiotoxicity;Ng;Semin Oncol,2006

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cynaroside regulates the AMPK/SIRT3/Nrf2 pathway to inhibit doxorubicin-induced cardiomyocyte pyroptosis;Journal of Zhejiang University-SCIENCE B;2024-09-12

2. Cardioprotection strategies for anthracycline cardiotoxicity;Basic Research in Cardiology;2024-09-09

3. Ferroptosis: A novel therapeutic target of natural products against doxorubicin-induced cardiotoxicity;Biomedicine & Pharmacotherapy;2024-09

4. Cancer and Heart Failure: Dangerous Liaisons;Journal of Cardiovascular Development and Disease;2024-08-27

5. Navigating cancer therapy induced cardiotoxicity: From pathophysiology to treatment innovations;Advanced Drug Delivery Reviews;2024-08